Hyperperfusion Syndrome After Intracranial Angioplasty and Stent Placement
2006; Lippincott Williams & Wilkins; Volume: 37; Issue: 9 Linguagem: Inglês
10.1161/01.str.0000237208.77716.1c
ISSN1524-4628
AutoresPhilip M. Meyers, Constantine C. Phatouros, Randall T. Higashida,
Tópico(s)Intracranial Aneurysms: Treatment and Complications
ResumoHomeStrokeVol. 37, No. 9Hyperperfusion Syndrome After Intracranial Angioplasty and Stent Placement Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBHyperperfusion Syndrome After Intracranial Angioplasty and Stent Placement Philip M. Meyers, MD Constantine C. Phatouros, MBBS, FRANZCR Randall T. Higashida, MD Philip M. MeyersPhilip M. Meyers Columbia Unversity, College of Physicians & Surgeons, Neurological Institute, New York, New York Constantine C. PhatourosConstantine C. Phatouros Royal Perth Hospital, Perth, Australia Randall T. HigashidaRandall T. Higashida University of California at San Francisco, San Francisco, California Originally published3 Aug 2006https://doi.org/10.1161/01.STR.0000237208.77716.1cStroke. 2006;37:2210–2211Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: August 3, 2006: Previous Version 1 To the Editor:Rezende et al1 incorrectly state that there is no prior report in the literature of hyperperfusion syndrome after stent revascularization of the intracranial vertebral artery. In fact, a nearly identical case was published with imaging proof of hyperperfusion based on cerebral blood flow (Figure) nearly 6 years ago in Neurosurgery. Download figureDownload PowerPointCerebral hyperperfusion after stenting in a 77-year-old man with crescendo vertebrobasilar insufficiency, despite heparin anticoagulation and the use of antiplatelet agents. A, Angiogram, demonstrating preocclusive (>90%) narrowing of the right vertebrobasilar junction. The left vertebral artery was occluded in the neck, and it was reconstituted by retrograde filling from the vertebrobasilar junction. B, Angiogram, after stenting, showing that the vertebral and basilar arteries are widely patent. C, Xenon-enhanced CT scan, before treatment, demonstrating decreased cerebral blood flow of 28 to 30 mL/100 g tissue per minute (arrowheads). D, 36-Hour post-treatment xenon-enhanced CT scan, showing quantitatively elevated perfusion of the posterior circulation with relative cerebral blood flow of 61 to 66 mL/100 g tissue per minute (arrowheads).In July 2000, authors working at the University of California, San Francisco, were the first to publish a series examining the incidence of intracranial hemorrhage and cerebral hyperperfusion syndrome after cervical and cerebral stent placement.2 In our series of 140 patients at that time, the incidence of cerebral hyperperfusion was 5%, whereas the incidence of intracranial hemorrhage was 1.4%, but with 0% mortality. We also reported on patients with clinical or radiological manifestations of cerebral hyperperfusion syndrome without intracerebral hemorrhage, something the current authors did not attempt. Indeed, we observed the major contribution to the 5% incidence of cerebral hyperperfusion syndrome were these cases.The incidence of intracranial hemorrhage after surgical carotid endarterectomy is &0.6%. In agreement with Rezende, this risk is increased by the presence of profound cerebral ischemia with impaired hemodynamic reserve.3 However, Rezende fails to indicate that other reports examining the incidence of cerebral hyperperfusion syndrome using perioperative transcranial Doppler studies have reported rates of up to 9%.4,5 Because the clinical findings in cerebral hyperperfusion syndrome may be subtle and ancillary investigations examining postprocedural cerebral blood flow, such as brain perfusion CT, nuclear medicine single-photon emission CT, xenon CT, and transcranial Doppler sonography, are not often performed, one may expect a significant reporting bias that can skew the published data.Normal systemic blood pressure ("normotension") after a revascularization procedure is often excessive blood pressure (effective "hypertension") in the susceptible cerebral circulation. Already a low resistance system, the brain can sustain severe barotrauma because of the loss of cerebrovascular tone and reactivity. Our patient detailed in the Figure sustained a 100% increase in cerebral blood flow after stent revascularization meeting the specific definition of hyperperfusion. In general, pharmacologically induced hypotension is required in these cases while taking into account comorbidities which could be exacerbated by hypotension. In the future, imaging may better guide pharmacotherapy on an individualized patient basis.Anticoagulation in the treatment of cerebral artery stenosis remains controversial, but one thing is clear: strong or multiple anticoagulants can cause cerebral hemorrhage. In both retrospective and prospective WASID studies, hemorrhagic complications substantially offset the benefit of anticoagulation for patients with posterior circulation stenosis.6,7 The WARSS trial found no benefit to warfarin over aspirin.8 Similarly, platelet inhibition must be used judiciously to balance the need to prevent stent thrombosis with the risk of hemorrhage. In carotid stent series using abciximab (a strong glycoprotein IIb/IIIa platelet inhibitor), there was a significant risk of cerebral hemorrhage.9,10 Although some authors advocate continued heparin infusion after neuroendovascular stent procedures, the coronary literature indicates little effect on the rate of stent thrombosis but a significant risk of hemorrhagic complications.11,12 Consequently, we use relatively smaller doses of heparin during revascularization procedures in which patients already take aspirin and clopidogrel, and we do not continue heparin after conclusion of the procedure.With the advent of the Boston Scientific Wingspan system, and others like it, we are entering a time when routine stenting of cerebral arteries becomes possible. It is incumbent on the greater neuroscience community to maximize our knowledge based on the available case material in order to advance the field. We cannot afford to reinvent the wheel on a periodic basis. Our cardiological colleagues luxuriate in a relative abundance of treatable disease. To their credit, however, cardiology has masterfully engineered trial after trial to evaluate drugs, devices, and techniques. Neurosciences need to follow this example to advance our discipline at a commensurate rate.DisclosuresNone.1 Rezende MT, Spelle L, Mounayer C, Piotin M, Abud DG, Moret J. Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke. 2006; 37: e12–e14.LinkGoogle Scholar2 Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000; 47: 335–343.CrossrefMedlineGoogle Scholar3 Kaku Y, Yoshimura S, Kokuzawa J. Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004; 25: 1403–1408.MedlineGoogle Scholar4 Gossetti B, Martinelli O, Guerricchio R, Irace L, Benedetti-Valentini F. Transcranial doppler in 178 patients before, during, and after carotid endarterectomy. 1997; 7: 213–216.Google Scholar5 Dalman JE, Beenakkers IC, Moll FL, Leusink JA, Ackerstaff RG. Transcranial doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg. 1999; 18: 222–227.CrossrefMedlineGoogle Scholar6 Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ. The warfarin-aspirin symptomatic intracranial disease study. Neurology. 1995; 45: 1488–1493.CrossrefMedlineGoogle Scholar7 Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005; 352: 1305–1316.CrossrefMedlineGoogle Scholar8 Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. 2001; 345: 1444–1451.Google Scholar9 Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002; 33: 1916–1919.LinkGoogle Scholar10 Qureshi AI, Suri MF, Ali Z, Kim SH, Lanzino G, Fessler RD, Ringer AJ, Guterman LR, Hopkins LN. Carotid angioplasty and stent placement: A prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery. 2002; 50: 466–473;discussion 473–465.MedlineGoogle Scholar11 Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB 3rd. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989; 117: 777–782.CrossrefMedlineGoogle Scholar12 Friedman HZ, Cragg DR, Glazier SM, Gangadharan V, Marsalese DL, Schreiber TL, O'Neill WW. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol. 1994; 24: 1214–1219.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Yang B, Kang K, Gao F, Mo D, Tong X, Song L, Sun X, Liu L, Huo X, Miao Z and Ma N Association of occlusion time with successful endovascular recanalization in patients with symptomatic chronic intracranial total occlusion, Journal of Neurosurgery, 10.3171/2021.12.JNS212337, (1-10) Diana F, Frauenfelder G, Botto A, Saponiero R and Romano D (2021) Cerebral hyperperfusion syndrome after intracranial stenting: Case report and systematic review, Interventional Neuroradiology, 10.1177/15910199211011860, 27:6, (843-849), Online publication date: 1-Dec-2021. Stapleton C, Chen Y, Shallwani H, Vakharia K, Turan T, Woo H, Derdeyn C, Charbel F, Siddiqui A and Amin-Hanjani S (2020) Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease, Neurosurgery, 10.1093/neuros/nyz337, 86:6, (755-762), Online publication date: 1-Jun-2020. Togashi S, Shimizu H and Suda Y (2020) Utility of Near-infrared Spectroscopy Monitoring in the Management of Hyperperfusion Syndrome after Intracranial Carotid Artery Stenting, NMC Case Report Journal, 10.2176/nmccrj.cr.2020-0003, 7:4, (223-227), . Male S, Nickele C and Elijovich L (2016) Critical Care of Brain Reperfusion, Current Neurology and Neuroscience Reports, 10.1007/s11910-016-0624-y, 16:3, Online publication date: 1-Mar-2016. Maramattom B (2016) Cerebral hyperperfusion syndrome after intracranial stenting of the middle cerebral artery, Indian Journal of Critical Care Medicine, 10.4103/0972-5229.192064, 20:10, (620-621), Online publication date: 1-Oct-2016. Kim J, Lee J, Jo K and You S (2013) Bilateral Superior Cerebellar Artery Infarction after Stent-Angioplasty for Internal Carotid Artery Stenosis, Journal of Korean Neurosurgical Society, 10.3340/jkns.2013.54.3.239, 54:3, (239), . Guo Z, Yang G, Zhang H, Wang S and Yang Y (2014) Hyperperfusion Secondary to Middle Cerebral Artery Stenting, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 10.1017/S031716710001355X, 39:3, (383-384), Online publication date: 1-May-2012. Kim D, Choi S, Yoon W and Kim B (2012) Hyperperfusion Syndrome after Carotid Stent-Supported Angioplasty in Patients with Autonomic Dysfunction, Journal of Korean Neurosurgical Society, 10.3340/jkns.2012.52.5.476, 52:5, (476), . Heran M, Sangha B and White C (2011) Renal hyperperfusion injury resulting in transient proteinuria post renal artery angioplasty for fibromuscular dysplasia, Pediatric Radiology, 10.1007/s00247-011-2207-z, 42:4, (491-494), Online publication date: 1-Apr-2012. Kim D, Kim B, Park H and Chung J (2011) Retinal hemorrhage as an initial sign of cerebral hyperperfusion syndrome after carotid artery stenting, Acta Neurochirurgica, 10.1007/s00701-011-1194-z, 154:1, (75-77), Online publication date: 1-Jan-2012. Koh J, Lee S, Ryu C and Kim E (2010) Hypoperfusion Infarctions of Unexpected Territories after Angioplasty of Intracranial Stenoses, Neurointervention, 10.5469/neuroint.2010.5.1.48, 5:1, (48), . Casas J, Gil de Bernabé M, Martín M and Rivilla M (2009) Anestesia en neurorradiología intervencionista, Revista Española de Anestesiología y Reanimación, 10.1016/S0034-9356(09)70409-8, 56:6, (361-371), Online publication date: 1-Jan-2009. Sfyroeras G, Karkos C, Arsos G, Liasidis C, Dimitriadis A, Papazoglou K and Gerassimidis T (2009) Cerebral Hyperperfusion After Carotid Stenting: A Transcranial Doppler and SPECT Study, Vascular and Endovascular Surgery, 10.1177/1538574408324510, 43:2, (150-156), Online publication date: 1-Apr-2009. Grunwald I, Politi M, Reith W, Krick C, Karp K, Zimmer A, Struffert T, Roth C, Kühn A, Haass A and Papanagiotou P (2008) Hyperperfusion syndrome after carotid stent angioplasty, Neuroradiology, 10.1007/s00234-008-0483-6, 51:3, (169-174), Online publication date: 1-Mar-2009. Medel R, Crowley R and Dumont A Hyperperfusion syndrome following endovascular cerebral revascularization, Neurosurgical Focus, 10.3171/2009.1.FOCUS08276, 26:3, (E4) Fàbregas N and Bruder N (2007) Recovery and neurological evaluation, Best Practice & Research Clinical Anaesthesiology, 10.1016/j.bpa.2007.06.006, 21:4, (431-447), Online publication date: 1-Dec-2007. Marco C, Daniele A, Ilaria E and Daniele Giuseppe R (2021) Neuroimaging of intracranial stenosis, Journal of Advanced Health Care, 10.36017/JAHC2109-003 Ghuman M, Tsang A, Klostranec J and Krings T (2019) Sentinel Angiographic Signs of Cerebral Hyperperfusion after Angioplasty and Stenting of Intracranial Atherosclerotic Stenosis: A Technical Note, American Journal of Neuroradiology, 10.3174/ajnr.A6149 September 2006Vol 37, Issue 9 Advertisement Article InformationMetrics https://doi.org/10.1161/01.STR.0000237208.77716.1cPMID: 16888253 Originally publishedAugust 3, 2006 PDF download Advertisement
Referência(s)